אביליפיי 10 מ"ג

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

ARIPIPRAZOLE 10 MG

Mevcut itibaren:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

ATC kodu:

N05AX12

Farmasötik formu:

TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

BRISTOL-MYERS SQUIBB S.R.L, ITALY

Terapötik grubu:

ARIPIPRAZOLE

Terapötik endikasyonlar:

Abilify is indicated for the treatment of schizophrenia. And for the treatment of moderate to severe manic episodes in Bipolar I disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.

Yetkilendirme tarihi:

2010-02-01